SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-187636
Filing Date
2023-07-17
Accepted
2023-07-17 07:06:04
Documents
51
Period of Report
2023-07-17
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d530903d8k.htm   iXBRL 8-K 24206
2 EX-99.1 d530903dex991.htm EX-99.1 37017
6 GRAPHIC g530903ex99_1p10g1.jpg GRAPHIC 272358
7 GRAPHIC g530903ex99_1p11g1.jpg GRAPHIC 293028
8 GRAPHIC g530903ex99_1p12g1.jpg GRAPHIC 89546
9 GRAPHIC g530903ex99_1p13g1.jpg GRAPHIC 276327
10 GRAPHIC g530903ex99_1p14g1.jpg GRAPHIC 291294
11 GRAPHIC g530903ex99_1p15g1.jpg GRAPHIC 274083
12 GRAPHIC g530903ex99_1p16g1.jpg GRAPHIC 301328
13 GRAPHIC g530903ex99_1p17g1.jpg GRAPHIC 330397
14 GRAPHIC g530903ex99_1p18g1.jpg GRAPHIC 225773
15 GRAPHIC g530903ex99_1p19g1.jpg GRAPHIC 293940
16 GRAPHIC g530903ex99_1p1g1.jpg GRAPHIC 199946
17 GRAPHIC g530903ex99_1p20g1.jpg GRAPHIC 212204
18 GRAPHIC g530903ex99_1p21g1.jpg GRAPHIC 89816
19 GRAPHIC g530903ex99_1p22g1.jpg GRAPHIC 221402
20 GRAPHIC g530903ex99_1p23g1.jpg GRAPHIC 266438
21 GRAPHIC g530903ex99_1p24g1.jpg GRAPHIC 316045
22 GRAPHIC g530903ex99_1p25g1.jpg GRAPHIC 307972
23 GRAPHIC g530903ex99_1p26g1.jpg GRAPHIC 296659
24 GRAPHIC g530903ex99_1p27g1.jpg GRAPHIC 258696
25 GRAPHIC g530903ex99_1p28g1.jpg GRAPHIC 224174
26 GRAPHIC g530903ex99_1p29g1.jpg GRAPHIC 81963
27 GRAPHIC g530903ex99_1p2g1.jpg GRAPHIC 637549
28 GRAPHIC g530903ex99_1p30g1.jpg GRAPHIC 291594
29 GRAPHIC g530903ex99_1p31g1.jpg GRAPHIC 213736
30 GRAPHIC g530903ex99_1p32g1.jpg GRAPHIC 269225
31 GRAPHIC g530903ex99_1p33g1.jpg GRAPHIC 247253
32 GRAPHIC g530903ex99_1p34g1.jpg GRAPHIC 225244
33 GRAPHIC g530903ex99_1p35g1.jpg GRAPHIC 61629
34 GRAPHIC g530903ex99_1p36g1.jpg GRAPHIC 369671
35 GRAPHIC g530903ex99_1p37g1.jpg GRAPHIC 284336
36 GRAPHIC g530903ex99_1p3g1.jpg GRAPHIC 313575
37 GRAPHIC g530903ex99_1p4g1.jpg GRAPHIC 238901
38 GRAPHIC g530903ex99_1p5g1.jpg GRAPHIC 233902
39 GRAPHIC g530903ex99_1p6g1.jpg GRAPHIC 78559
40 GRAPHIC g530903ex99_1p7g1.jpg GRAPHIC 296170
41 GRAPHIC g530903ex99_1p8g1.jpg GRAPHIC 263360
42 GRAPHIC g530903ex99_1p9g1.jpg GRAPHIC 223122
43 GRAPHIC g530903g0715064932342.jpg GRAPHIC 2413
  Complete submission text file 0001193125-23-187636.txt   13113435

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vrdn-20230717.xsd EX-101.SCH 2889
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrdn-20230717_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrdn-20230717_pre.xml EX-101.PRE 11287
45 EXTRACTED XBRL INSTANCE DOCUMENT d530903d8k_htm.xml XML 3396
Mailing Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453
Business Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36483 | Film No.: 231090489
SIC: 8071 Services-Medical Laboratories